UnitedHealth’s Q1 Medical Cost Update, Prudent Outlook Eases Investor Concerns: Goldman Sachs
UnitedHealth impresses with Q1 results amid the aftermath of the Change Healthcare cyberattack and maintains strong guidance amidst business disruption costs. Goldman Sachs reaffirms Buy rating, citing favorable medical cost updates and prudent outlook, despite cyberattack-related challenges.